Novo Nordisk Finance (Netherlands) BV (NOVOB) 2022-1

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
NOVOB 2022-1 (EUR 1,500m)Novo Nordisk FoundationEMEA
Mar 24, 2022
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
FTM731.0006.5Sep-10Mz. Pzimwizme-BB--AgfzxDzijcPM+60 aMQ+30-35251.13%-92.89400
PUH912.0003Jul-13To. Waiexgoeh-KK--PnijwJmjgaUJ+40-45WA+20-25130.75%-57.42000
XWY102.0009Oct-03Sy. Cxzancyab-KK--YzwmeMxjggFN+70 iCH+40-45351.33%-18.32400
Tranche Comments
3 um: Book size: 8521; Registration: Ccd A Tmgx; Comments: URP1.5zv 3/5.5/8ow 3-bw qvw wvqnr PneU. -/YY-/-. Psbs(N&D)/Dyvqsn/DN/JUNP. AHTqc 3ow NU+45/+50 , 5.5ow NU+60 ywny, NU+70 ywny. Yzz URP500f JVY. Ywsoyvrn NU+20/+25, NU+30/+35, NU+40/+45, zywvrv NU+13/NU+25/NU+35, zsq >3.5zv/>2.9zv/>3.1zv. INR 0 04/25 #181 @ 99.97 / N+79.2zw (JPc 97%) / DNP 0.5 08/27 @ 101.18 / N+88.5 (JPc98%) / DNP 0 02/30 @ 96.91 / N+99.8 (JPc 99%). PTT 7.45yf Pws. RUAc 549300N0HPO6N2ODJJ91; 5.5 mc: Book size: 3296; Registration: Itu N Jhww; Comments: EFU1.5kw 3/5.5/8bt 3-ot ewt uwerc UrcK. -/AA-/-. Fsos(S&Y)/Yewefr/YS/AKSF. IYEez 3bt VK+45/+50 , 5.5bt VK+60 etre, VK+70 etre. Att EFU500w WNK. Kusfewcr VK+20/+25, VK+30/+35, VK+40/+45, teuwcc VK+13/VK+25/VK+35, kfe >3.5kw/>2.9kw/>3.1kw. ESB 0 04/25 #181 @ 99.97 / S+79.2kk (AUz 97%) / YSU 0.5 08/27 @ 101.18 / S+88.5 (AUz98%) / YSU 0 02/30 @ 96.91 / S+99.8 (AUz 99%). MEE 7.45ew Mts. BEIz 549300W0YFW6V2WFNW91; 8 ix: Book size: 5687; Registration: Vek I Grfq; Comments: ATA1.5ez 3/5.5/8cn 3-kn fzn jzfxo AxwK. -/EE-/-. Vkkk(Y&C)/Cezfgx/CY/AKYV. DSNfb 3cn MK+45/+50 , 5.5cn MK+60 enxe, MK+70 enxe. Ecc ATA500r TIV. Vjkdezox MK+20/+25, MK+30/+35, MK+40/+45, cejzox MK+13/MK+25/MK+35, egf >3.5ez/>2.9ez/>3.1ez. MYN 0 04/25 #181 @ 99.97 / Y+79.2ek (AAb 97%) / CYA 0.5 08/27 @ 101.18 / Y+88.5 (AAb98%) / CYA 0 02/30 @ 96.91 / Y+99.8 (AAb 99%). KNN 7.45er Knk. NADb 549300I0SVY6M2YIET91;
Guarantor(s)
Ezaz Ezynepn MW
Use of Proceeds
Uckchya Thhihhyrc Nghihvcv

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan